The Patient Advocate for PGx | PGX for Pharmacists

According to the American Association for Cancer Research, 80-90% of the administered dose of the cancer medication 5-fluorouracil of 5FU is degraded by the enzyme dihydropyridine dehydrogenase or DPD for short. (https://clincancerres.aacrjournals.org/content/5/8/2006). According to the Institute …

Changing Your Life as a Pharmacist | Dr. Jamie Wilkey | PGX for Pharmacists

Jamie grew up in a small town in Wyoming where she got her start in pharmacy working at the local City Drug. She attended the University of Wyoming School of Pharmacy for her Doctor of Pharmacy. For 10 years post-graduation Jamie worked in community pharmacy while having and raising her 4 little bo…

Expanding PGx Education Programs | PGX for Pharmacists

Implementing Pharmacogenomics into the Education of the PharmD  How do interested faculty start a program for PGx education at their own school? Today’s episode builds on the experiences of David Hurley in developing a PGx program at the Gatton College of Pharmacy. His training provides ALL first…

Better Utilization of the Pharmacist's Expertise | PGX for Pharmacists

How can we leverage pharmacists to help patients transition better and also allow the providers use the expertise of pharmacists? According to the peer review journal JAMA (Journal of American Medical Association), to improve care when patients transition from a facility such as a hospital to thei…

PGX in Mental Health | PGx for Pharmacists

Dr. Jessica Whelan has extensive experience in the mental health field and has served as a speaker and advisory board member in many areas including psychopharmacology and pharmacogenomics. Dr. Whelan is the CEO of a national network of clinicians with Holon Inclusive Health System and adjunct fac…

Improving Market Access and Reimbursement for PGX Diagnostics | PGX for Pharmacists

ALVA10: the Power of Diagnostics  Have you ever questioned why a payer pays for a medication, yet does not pay for the diagnostic test to determine if the medication will be efficacious and non-toxic for the patient? Or perhaps, you may have wondered why payers agree to pay for a medication for w…

Pharmacogenomics Leader Series: Howard McLeod | PGX for Pharmacists

Today's episode of the PGX for Pharmacists podcast is hosted by Dr. Becky Winslow, PharmD. Dr. Winslow is a pharmacogenomics authority with more than twenty years of clinical pharmacotherapy and pharmacy business operations experience, which includes seven years of direct patient facing care, seven…

Geriatric Pharmacist - DeLon Canterbury, PharmD | PGx for Pharmacists

DeLon Canterbury is a Board Certified Geriatric Pharmacist.  He founded GeriatRx, a telehealth-based senior care consulting company.  GeriatRx combines Pharmacogenomic testing and Comprehensive Medication Management. He addresses the social determinants of health. He helps reduce medication errors …

The State of PGx Education (Part 2) | PGX for Pharmacists

PART TWO: Pharmacogenomics Education is critical to advancing the Pharmacist's optimal impact on medication management as a tool to ensure the drugs prescribed work as intended.  The State of the Industry -- Pharmacogenomics Education Clinical pharmacogenomics activities may include designing pat…

The Pharmacogenomics Fellowship| PGX For Pharmacists

Dr. Jai Patel, PharmD, BCOP, CPP Chair of Department of Cancer Pharmacology & Pharmacogenomics Dr. Jai Patel is a pharmacist who help create a pharmacogenomics fellowship which was not available at his school. He finished the Oncology/Pharmacogenomics Postdoctoral Fellowship at the UNC Eshelman S…